Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Amgen Outsources Celiac Drug To Provention; Lilly, NextCure Will Co-Discover IO Drugs

Nov 08 2018

• By Joseph Haas and Mandy Jackson

DealWatch_1200x675

Related Content

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Oct 23 2018

Takeda Offers Shire Asset Disposal To Assuage EC Merger Concerns

Oct 29 2018

Lilly Puts Down $200m To Use Dicerna's RNAi Platform For Metabolic, Neurological Diseases

Oct 29 2018

Pfizer/Novartis Collaboration Brings Combined Strength To NASH Development

Oct 29 2018

AZ Cashes In On No-Longer Core Nexium

Oct 30 2018

Aeterna Zentaris tanks on FDA Macrilen rejection

Nov 07 2014

Immuno-Oncology Startup Snatches $67m In Series A

Jan 08 2016

Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal

Nov 29 2017

Provention Builds On J&J Disease Interception Model

Sep 21 2017

KemPharm Plans To License Out Commercial Rights For Pain, ADHD Candidates

Nov 18 2017

KemPharm And The Curious Case Of Launching A Brand Opioid Like A Generic

Feb 26 2018

Novo Nordisk, Embark Seek Obesity Drugs That Boost Body's Energy Use

Nov 02 2018

Sanofi Stumps Up $125m To Access Denali RIPK1 Inhibitors

Nov 01 2018

$1.6bn ARMO Buy Gives Lilly Its Most Advanced Immuno-Oncology Asset

May 11 2018

Yuhan Strikes Long-Awaited Lung Cancer Deal Through Huge Janssen Alliance

Nov 06 2018

Genentech's Immunology/Infectious Disease Deal Maker On Following The Science

Nov 07 2018

AZ Clears Out Three Respiratory Drugs With Sale To Covis

Nov 06 2018

Better Together: New Deal Adds Weight To China Biosimilar/Biobetter Swap

Nov 07 2018

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Aug 01 2018

BioNotebook: Denovo, Celimmune revive Lilly, Amgen programs; Malin invests in Serenus; J&J opens fourth incubator; Blueprint, Alexion partner

Mar 04 2015

Related Companies

Amgen, Inc.

Provention Bio, Inc.

Celimmune LLC

Eli Lilly and Company

NextCure, Inc.

ARMO BioSciences, Inc.

Yale University

Zevra Therapeutics, Inc.

KVK Tech, Inc.

Aria Pharmaceuticals, Inc.

Strongbridge Biopharma plc

Novo Nordisk A/S

COSCIENS Biopharma

Gilead Sciences, Inc.

Tango Therapeutics, Inc.

Roche Holding AG

Halozyme Therapeutics, Inc.

Bristol Myers Squibb Company

Ionis Pharmaceuticals, Inc.

ProQR Therapeutics N.V.

Qpex Biopharma, Inc.

The Medicines Company

Novartis AG

IDEAYA Biosciences, Inc.

LEO Pharma A/S

Zymeworks, Inc.

Merck & Co., Inc.

Bristol Myers Squibb Company

Daiichi Sankyo Co., Ltd.

Melinta Therapeutics, Inc.

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window